Navigation Links
Chaffin Luhana Alerts Actos Patients to Updated MDL Trial Dates
Date:4/9/2013

a expanded after the June 2011 FDA warning concerning the link between Actos and bladder cancer (FDA Drug Safety Communication, 6/15/2011). The agency reviewed the five-year results of a 10-year ongoing epidemiological study, and reported that patients taking the type 2 diabetes drug for more than 12 months may be at a 40 percent increased risk of bladder cancer. In August 2011, the FDA approved updated drug labels that contained the new information (FDA Drug Safety Communication, 8/4/2011).

Judge Doherty noted in her order that the deadlines for the bellwether trials “should be considered hard and fast,” and will not be “extended, continued, or delayed” unless extraordinarily good cause is shown. She acknowledged that the schedule will place “extraordinary burdens” on the court, counsel and parties, but encouraged all to do what is necessary to prepare these trials to begin on time.

Chaffin Luhana LLP has a successful history of protecting the rights of those affected by the serious side effects of medications like Actos. Partners Eric Chaffin and Roopal Luhana represent high-profile cases in federal and state courts across the country, and provide new online resource centers for clients and the public. To date, Mr. Chaffin and Ms. Luhana along with co-counsel have been involved in recovering over $900 million for injured consumers. Both have been named to the prestigious New York Metro Super Lawyers list, and though unable to guarantee results, the firm has a distinguished track
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. TxtWatcher Alerts Parents About Kids Texting While Driving
2. Internet searches can identify drug safety issues well ahead of public alerts
3. NOAA adds red tide alerts to Beach Hazards Statements
4. DrugRisks Update: Doctor Testifies Actos Main Cause of Bladder Cancer in Trial
5. 2013 Actos Bladder Cancer Claims Now Being Investigated by Resource4thePeople Attorneys
6. DrugRisk Center Adds Latest on First of 3,000 Actos Bladder Cancer Trials
7. DrugRisks Adds Update from First Actos Trial of Patient Alleging Bladder Cancer
8. Drug Safety Center Update: Employee Alleges Actos Maker Valued Sales Over Safety
9. DrugRisk Update: Evidence Submitted in Actos Lawsuit Suggests Drug Maker Knew of Cancer Risks
10. Actos Lawsuit News: Bernstein Liebhard LLP Notes Latest Scheduling Order in Actos Bladder Cancer Litigation
11. US Drug Watchdog Now Urges All Diabetics Nationwide Who Used the Diabetes Drug Actos and now have Bladder Cancer to Call The Johnson Law Group For A Legal Evaluation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... rates rise in association with extremely hot weather. The ... 2003, for example, resulted in about 22,000 extra deaths. ... at the Institute of Epidemiology II at the Helmholtz ... the number of deaths caused by cardiovascular disease in ... temperatures in the study. , "Our findings confirm the ...
(Date:7/29/2014)... handle stressful situations better than others, and it,s ... show differences in how they respond. , Researchers ... brains of genetically identical mice that predicts how ... , The findings, published July 29 in ... prevent potential consequences of chronic stress -- such ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 Foot Levelers ... lecturer at the Florida Chiropractic Association (FCA) National Convention ... Effects on the Kinetic Chain Changes on Thursday, August ... talk is focusing on the positive impact functional foot ... such as low back pain, plantar fasciitis, and hammertoes. ...
(Date:7/29/2014)... Dallas, Texas (PRWEB) July 29, 2014 ... the Global Biosimilars Market report is an essential ... biosimilars industry. Using detailed company data, financial analysis, ... in-depth analysis of the current and future growth ... the various regulatory frameworks under which biosimilars are ...
(Date:7/29/2014)... Catalent Pharma Solutions, the global leader ... for pharmaceutical, biologic, and consumer health products, today ... US Platform Leader of Pharmaceutical Softgels, will present ... Formulations using Soft Capsule Delivery Systems” at the ... of Drug Delivery Systems (30-31 July 2014, Tokyo, ...
Breaking Medicine News(10 mins):Health News:Mortality rates increase due to extreme heat and cold 2Health News:A new brain-based marker of stress susceptibility 2Health News:Foot Levelers CEO Kent Greenawalt Speaking at FCA Convention 2Health News:World Biosimilars Market Value Exceed $262 Billion by 2019 Says a New Report Available at MarketOptimizer.org 2Health News:World Biosimilars Market Value Exceed $262 Billion by 2019 Says a New Report Available at MarketOptimizer.org 3Health News:World Biosimilars Market Value Exceed $262 Billion by 2019 Says a New Report Available at MarketOptimizer.org 4Health News:Catalent Expert to Present on Enhancing Bioavailability of Poorly Absorbed Drugs at Japan Society of Drug Delivery Systems 2
... of Oaks Development,Group announced today the company closed on ... 3603 Paesanos Parkway in north central,San Antonio. The ... 1604 and,Northwest Military Highway, will feature the company,s unique ... tenants, equity,investors and the developer. , ...
... and John Centrello decided to bank their baby,s cord blood with M.A.Z.E. ... hoping never to use it, but wanted to have it just in ... ... While pregnant, Danielle and John Centrello decided to bank their baby,s ...
... December 8, 2008Medical specialists at the nation,s largest professional ... have about data presented by the FDA in support ... and the potential effect of the federal agency,s analyses ... are to be conducted in the future. , It ...
... Unilens Vision Inc.,(OTC Bulletin Board: UVICF; TSX Venture ... specialty contact lenses,today announced the acquisition of the ... Inc. located in Michigan. , ... agreement, Unilens acquired certain assets of Aero,Contact Lens, ...
... chronic hepatitis C and advanced liver disease with long-term ... and liver inflammation, but the treatment did not slow ... study finds. , These findings come from the clinical ... and are reported in the Dec. 4 issue of ...
... Cancer Report Released by IARC; U.S. Groups List Six Critical Steps ... , ATLANTA, Dec. 9 Despite ... men and women in the United States continue to decline, cancer ... the year 2010, and low- and middle-income countries will feel the ...
Cached Medicine News:Health News:Oaks Development Group Closes on Third San Antonio Project 2Health News:Oaks Development Group Closes on Third San Antonio Project 3Health News:Local Child Treated In Clinical Trial To Ease Symptoms of Cerebral Palsy 2Health News:Local Child Treated In Clinical Trial To Ease Symptoms of Cerebral Palsy 3Health News:Local Child Treated In Clinical Trial To Ease Symptoms of Cerebral Palsy 4Health News:Unilens Vision Acquires Aero Contact Lens, Inc. 2Health News:Hepatitis C treatment reduces the virus but liver damage continues 2Health News:Hepatitis C treatment reduces the virus but liver damage continues 3Health News:Leading U.S. Cancer Organizations Unite Against the Growing Global Cancer Burden 2Health News:Leading U.S. Cancer Organizations Unite Against the Growing Global Cancer Burden 3Health News:Leading U.S. Cancer Organizations Unite Against the Growing Global Cancer Burden 4Health News:Leading U.S. Cancer Organizations Unite Against the Growing Global Cancer Burden 5Health News:Leading U.S. Cancer Organizations Unite Against the Growing Global Cancer Burden 6
(Date:7/29/2014)...  The Healthcare Analytics Summit 2014 (HAS ... Salt Lake City , Sept. 24-25 has added ... organizations in the U.S. and beyond.  HAS ,14, powered ... devoted to providing immersive learning experiences on the ... accountable care initiatives and population health managemen t ...
(Date:7/29/2014)... MOUNTAIN VIEW, Calif. , July 29, 2014 ... antivirals has amplified with rising incidence rates and ... absence of a preventative vaccine. Change is underway ... and interferon regimens towards highly effective, easily-tolerated, interferon-free ... http://photos.prnewswire.com/prnh/20140728/130662 Gilead,s mega blockbuster ...
(Date:7/29/2014)... LONDON , July 29, 2014 ... 2014 Global Frost & Sullivan Best Practices Award ... solution is a cloud-based platform that connects digital ... - such as providers, pharmaceutical companies, prevention and ... electronics. Each year, Frost & ...
Breaking Medicine Technology:Health Catalyst Adds Keynote Speakers, New Sessions, and Expands Attendee Limit for Healthcare Analytics Summit 2014 2Health Catalyst Adds Keynote Speakers, New Sessions, and Expands Attendee Limit for Healthcare Analytics Summit 2014 3Health Catalyst Adds Keynote Speakers, New Sessions, and Expands Attendee Limit for Healthcare Analytics Summit 2014 4Health Catalyst Adds Keynote Speakers, New Sessions, and Expands Attendee Limit for Healthcare Analytics Summit 2014 5A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 2A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 3A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 4Frost & Sullivan Commends Validic for Delivering Superior Customer Value through its mHealth Interoperability Technology Platform 2Frost & Sullivan Commends Validic for Delivering Superior Customer Value through its mHealth Interoperability Technology Platform 3Frost & Sullivan Commends Validic for Delivering Superior Customer Value through its mHealth Interoperability Technology Platform 4
... ZURICH , July 19, 2010 Today, Novo Nordisk ... designed to investigate the effects of modern insulins in,the management of type 2 diabetes.[1] ... Spanning 28 countries across ... largest observational study,in insulin therapy. , , ...
... July 16 Human erythropoietin (EPO) is a ... and spinal cord injury, and Parkinson,s disease. However, EPO drug ... cross the blood-brain barrier (BBB). In acute stroke or brain ... the insult when neuroprotection is still possible. Therefore, large molecule ...
Cached Medicine Technology:World's Largest Study on Insulin Therapy Completes Recruitment With 60,000 Patients 2World's Largest Study on Insulin Therapy Completes Recruitment With 60,000 Patients 3ArmaGen® Re-engineers Erythropoietin for Brain Penetration 2
... Used to dilate the lower ... to assess possible submucosal tunneling. ... topical anesthetic in the ureter. ... by, or dislodgment of a ...
Used for drainage and retrograde pyelogram. The spiral tip aids in negotiation of a tortuous or partially obstructed ureter. Supplied sterile in peel-open packages. Intended for one-time use....
... Used for the injection of contrast ... The dual lumen design eliminates the need ... designed to promote atraumatic passage into and ... layer of hydrophilic polymer that when activated, ...
Used for drainage and retrograde pyelogram. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: